doi: 10.1161/hq1201.100255
© 2001 American Heart Association, Inc.
Thrombosis |
Neutrophil Enhancement of Fibrin Deposition Under Flow Through Platelet-Dependent and -Independent Mechanisms
From the Institute for Medicine and Engineering, Department of Chemical Engineering, University of Pennsylvania, Philadelphia.
Correspondence to Dr Scott L. Diamond, Institute for Medicine and Engineering, Department of Chemical Engineering, University of Pennsylvania, 1010 Vagelos Research Laboratories, 3340 Smith Walk, Philadelphia, PA 19104. E-mail sld{at}seas.upenn.edu
We examined the effect of adherent neutrophils on fibrin deposition under laminar flow conditions. Perfusion of recalcified citrated platelet-free plasma (PFP) over neutrophils adherent to fibrinogen-coated glass at a venous wall shear rate of 62.5 s-1 for 15 minutes resulted in dense deposition of fibrin around each neutrophil, whereas fibrin deposition on glass alone was sparse. Fibrin deposition on neutrophils was markedly reduced by anti-CD18 or anti-CD11b or a higher shear rate (250 s-1). Significantly less fibrin was deposited around adherent fibrinogen-coated beads, indicating that nonspecific "cross-sectional capture" effects were not responsible for the massive fibrin deposition on neutrophils. Direct visualization of fibrin capture by neutrophils and elimination of fibrin deposition at 15 minutes by a factor XIIa inhibitor (50 µg/mL corn trypsin inhibitor [CTI]) or elastase/cathepsin G inhibitors (Methoxysuccinyl-Ala-Ala-Pro-Ala-Chloromethyl-Ketone/Z-Gly-Leu-Phe-CMK, 100 µmol/L) indicated that neutrophils can capture short fibrin strands flowing in recalcified PFP lacking CTI and can also promote thrombin generation through pathways attenuated by inhibitors of factor XIIa, elastase, and cathepsin G. When neutrophils were allowed to interact with platelets on a fibrinogen surface before perfusion of recalcified CTI-treated PFP, the fibrin deposition was observed to be dramatic compared with that over surfaces coated with platelets alone or neutrophils alone and compared with that formed on platelets adherent to collagen. This neutrophil promotion of platelet-mediated fibrin formation was attenuated by inhibitors of elastase or cathepsin G but not anti-tissue factor antibody. Neutrophils can interact with platelets via released proteases to increase platelet procoagulant activity and fibrin formation in CTI-treated plasma under the low-flow conditions expected in venous thrombosis or inflammation.
Key Words: P-selectin • CD11b/CD18 • thrombin • deep vein thrombosis
This article has been cited by other articles:
 |
|
 |
|
  U. M. Okorie and S. L. Diamond Matrix Protein Microarrays for Spatially and Compositionally Controlled Microspot Thrombosis under Laminar Flow Biophys. J., November 1, 2006; 91(9): 3474 - 3481. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.E. Husted, B.K. Ziegler, and A. Kher Long-term anticoagulant therapy in patients with coronary artery disease Eur. Heart J., April 2, 2006; 27(8): 913 - 919. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Psathakis, E. Calderon-Osuna, B. Romero-Romero, J. Martin-Juan, A. Romero-Falcon, and F. Rodriguez-Panadero The neutrophilic and fibrinolytic response to talc can predict the outcome of pleurodesis. Eur. Respir. J., April 1, 2006; 27(4): 817 - 821. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. S. Coller Leukocytosis and Ischemic Vascular Disease Morbidity and Mortality: Is It Time to Intervene? Arterioscler. Thromb. Vasc. Biol., April 1, 2005; 25(4): 658 - 670. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Hafezi-Moghadam, K. L. Thomas, and C. Cornelssen A novel mouse-driven ex vivo flow chamber for the study of leukocyte and platelet function Am J Physiol Cell Physiol, April 1, 2004; 286(4): C876 - C892. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Leon, M. Alex, A. Klocke, E. Morgenstern, C. Moosbauer, A. Eckly, M. Spannagl, C. Gachet, and B. Engelmann Platelet ADP receptors contribute to the initiation of intravascular coagulation Blood, January 15, 2004; 103(2): 594 - 600. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. B. Yee, J. R. Harkema, P. E. Ganey, and R. A. Roth The Coagulation System Contributes to Synergistic Liver Injury from Exposure to Monocrotaline and Bacterial Lipopolysaccharide Toxicol. Sci., August 1, 2003; 74(2): 457 - 469. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Zhang, Z. G. Zhang, R. L. Zhang, M. Lu, M. Krams, and M. Chopp Effects of a Selective CD11b/CD18 Antagonist and Recombinant Human Tissue Plasminogen Activator Treatment Alone and in Combination in a Rat Embolic Model of Stroke Stroke, July 1, 2003; 34(7): 1790 - 1795. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. S. Goel and Scott. L. Diamond Neutrophil Cathepsin G Promotes Prothrombinase and Fibrin Formation under Flow Conditions by Activating Fibrinogen-adherent Platelets J. Biol. Chem., March 7, 2003; 278(11): 9458 - 9463. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. S. Goel and S. L. Diamond Adhesion of normal erythrocytes at depressed venous shear rates to activated neutrophils, activated platelets, and fibrin polymerized from plasma Blood, November 15, 2002; 100(10): 3797 - 3803. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. C. Becker Antithrombotic Therapy after Myocardial Infarction N. Engl. J. Med., September 26, 2002; 347(13): 1019 - 1022. [Full Text] [PDF]
|
|